NEW YORK, Dec 12 – Oncosis said Tuesday it received a four-year, $6.7 million Small Business Innovation Research grant from the National Institutes of Health to develop its Photosis technology.
Photosis is an automated, laser-based cell treatment system that has clinical and genomic applications, the company said.
While the grant will at first be used to develop an instrument for tumor cell purging, Oncosis said that the technology could also be used for gene expression profiling and cell selection and purification.
Manfred Koller, Oncosis' vice president R&D, said in a statement that the science behind the optical scanning and laser system used in cell treatment stemmed from the government's research in the Star Wars program in the 1980s.
The technology has so far been applied to such industries as computer chip manufacturing, which require a high degree of laser speed, accuracy, and precision.